LeMaitre Vascular Past Earnings Performance
Past criteria checks 5/6
LeMaitre Vascular has been growing earnings at an average annual rate of 13.3%, while the Medical Equipment industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 12.5% per year. LeMaitre Vascular's return on equity is 12.5%, and it has net margins of 19.4%.
Key information
13.3%
Earnings growth rate
10.4%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 12.5% |
| Return on equity | 12.5% |
| Net Margin | 19.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Nov 03LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 02
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?
Oct 08Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Revenue & Expenses Breakdown
How LeMaitre Vascular makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 213 | 41 | 80 | 16 |
| 30 Jun 24 | 206 | 38 | 77 | 17 |
| 31 Mar 24 | 200 | 34 | 75 | 17 |
| 31 Dec 23 | 193 | 30 | 73 | 17 |
| 30 Sep 23 | 186 | 27 | 70 | 16 |
| 30 Jun 23 | 177 | 25 | 68 | 15 |
| 31 Mar 23 | 169 | 21 | 65 | 14 |
| 31 Dec 22 | 162 | 21 | 62 | 13 |
| 30 Sep 22 | 160 | 21 | 60 | 13 |
| 30 Jun 22 | 160 | 22 | 58 | 13 |
| 31 Mar 22 | 158 | 27 | 55 | 12 |
| 31 Dec 21 | 154 | 27 | 53 | 12 |
| 30 Sep 21 | 152 | 28 | 51 | 11 |
| 30 Jun 21 | 151 | 29 | 49 | 10 |
| 31 Mar 21 | 135 | 24 | 46 | 10 |
| 31 Dec 20 | 129 | 21 | 46 | 10 |
| 30 Sep 20 | 122 | 19 | 47 | 10 |
| 30 Jun 20 | 115 | 16 | 48 | 10 |
| 31 Mar 20 | 119 | 18 | 50 | 10 |
| 31 Dec 19 | 117 | 18 | 49 | 9 |
| 30 Sep 19 | 115 | 19 | 48 | 9 |
| 30 Jun 19 | 111 | 18 | 47 | 9 |
| 31 Mar 19 | 108 | 23 | 46 | 9 |
| 31 Dec 18 | 106 | 23 | 45 | 8 |
| 30 Sep 18 | 103 | 21 | 44 | 7 |
| 30 Jun 18 | 104 | 22 | 44 | 7 |
| 31 Mar 18 | 103 | 18 | 43 | 7 |
| 31 Dec 17 | 101 | 17 | 43 | 7 |
| 30 Sep 17 | 98 | 15 | 43 | 7 |
| 30 Jun 17 | 96 | 14 | 43 | 6 |
| 31 Mar 17 | 93 | 12 | 42 | 6 |
| 31 Dec 16 | 89 | 11 | 40 | 6 |
| 30 Sep 16 | 86 | 11 | 39 | 6 |
| 30 Jun 16 | 82 | 9 | 38 | 6 |
| 31 Mar 16 | 79 | 9 | 37 | 6 |
| 31 Dec 15 | 78 | 8 | 37 | 5 |
| 30 Sep 15 | 76 | 7 | 36 | 5 |
| 30 Jun 15 | 74 | 6 | 36 | 5 |
| 31 Mar 15 | 73 | 5 | 36 | 4 |
| 31 Dec 14 | 70 | 4 | 36 | 5 |
| 30 Sep 14 | 70 | 3 | 36 | 5 |
| 30 Jun 14 | 67 | 3 | 36 | 5 |
| 31 Mar 14 | 65 | 2 | 36 | 5 |
| 31 Dec 13 | 64 | 3 | 35 | 5 |
Quality Earnings: LMAT has high quality earnings.
Growing Profit Margin: LMAT's current net profit margins (19.4%) are higher than last year (14.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LMAT's earnings have grown by 13.3% per year over the past 5 years.
Accelerating Growth: LMAT's earnings growth over the past year (51.5%) exceeds its 5-year average (13.3% per year).
Earnings vs Industry: LMAT earnings growth over the past year (51.5%) exceeded the Medical Equipment industry 12.6%.
Return on Equity
High ROE: LMAT's Return on Equity (12.5%) is considered low.